3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
15
HER2-positive Breast Cancer
4
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Salivary Gland Neoplasms
1
Non-squamous NSCLC
1
Non Small Cell Lung
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
1
Breast Cancer Invasive
1
Breast Cancer Female
1
Advanced Digestive System Tumor
1
Advanced Breast Cancer
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2+ Breast Cancer
×
pyrotinib
×
1 year
×
Clear all
No trials found.